Omada Health (OMDA) Stock Price, News & Analysis

Company Overview

Omada Health, Inc. is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines clinical care, health coaching, connected devices, digital tools and personalized support to help members improve health outcomes and manage conditions over time.

The company’s offerings address areas including diabetes, hypertension, weight health and musculoskeletal conditions. Omada’s programs are designed to support prevention and ongoing care through services such as remote monitoring, personalized health guidance, educational content and access to healthcare professionals.

Omada primarily serves members through employers, health plans and healthcare organizations in the United States. The company was founded in 2011 and is led by co-founder Sean Duffy, who serves as chief executive officer.

Key Stats

• Today's Range: $20.18 to $21.52
• 50-Day Range: $19.11 to $24.99
• 52-Week Range: $10.28 to $26.92
• Volume: 634,479 shs
• Average Volume: 1.28 million shs
• Market Capitalization: $1.31 billion
• P/E Ratio: 427.10
• Dividend Yield: N/A
• Price Target: $26.67
• Consensus Rating: Moderate Buy

Omada Health Stock Analysis - MarketRank™

Omada Health scored higher than 80% of companies evaluated by MarketBeat, and ranked 120th out of 898 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Omada Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.71, and is based on no strong buy ratings, 11 buy ratings, 2 hold ratings, and 1 sell rating.

Upside Potential

Omada Health has a consensus price target of $26.67, representing about 31.2% upside from its current price of $20.33.

Amount of Analyst Coverage

Omada Health has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 100.00%

Earnings Growth

Earnings for Omada Health are expected to grow by 100.00% in the coming year, from $0.09 to $0.18 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Omada Health is 406.40, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.09.

Price to Earnings Ratio vs. Sector

The P/E ratio of Omada Health is 406.40, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.61.

Price to Book Value per Share Ratio

Omada Health has a P/B Ratio of 5.12. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

10.02% of the float of Omada Health has been sold short.

Short Interest Ratio / Days to Cover

Omada Health has a short interest ratio ("days to cover") of 6.46.

Change versus previous month

Short interest in Omada Health has recently decreased by 2.46%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Omada Health does not currently pay a dividend.

Dividend Growth

Omada Health does not have a long track record of dividend growth.

News and Social Media

• Score: 3.2 / 5
• News Sentiment: 1.12

News Sentiment

Omada Health has a news sentiment score of 1.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.51 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Omada Health this week, compared to 4 articles on an average week.

MarketBeat Follows

5 people have added Omada Health to their MarketBeat watchlist in the last 30 days. This is an increase of 400% compared to the previous 30 days.

Company Ownership

• Score: 0.9 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Omada Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,909,653.00 in company stock.

Percentage Held by Insiders

6.38% of the stock of Omada Health is held by insiders.

Percentage Held by Institutions

Omada Health has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 9/22/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:OMDA
• Previous Symbol: NASDAQ:OMDA
• CIK: 1611115
• Web: www.omadahealth.com
• Phone: (888) 987-8337
• Fax: N/A
• Employees: 946
• Year Founded: 2011

Price Target and Rating

• Average Price Target for Omada Health: $26.67
• High Price Target: $35.00
• Low Price Target: $18.00
• Potential Upside/Downside: +25.0%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.71
• Research Coverage: 14 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.05
• Trailing P/E Ratio: 427.10
• Forward P/E Ratio: 236.96
• P/E Growth: N/A
• Net Income: -$12.78 million
• Net Margins: 1.39%
• Pretax Margin: 1.39%
• Return on Equity: 2.60%
• Return on Assets: 1.98%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.91
• Quick Ratio: 3.85

Sales & Book Value

• Annual Sales: $309.76 million
• Price / Sales: 4.21
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $3.97 per share
• Price / Book: 5.37

Miscellaneous

• Outstanding Shares: 61,217,000
• Free Float: 57,311,000
• Market Cap: $1.31 billion
• Optionable: N/A
• Beta: 1.86